Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Medical Oncology (Northwood, London, England)|September 9, 2018
Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysisNoriyoshi Iriyama, Kei-Ji Sugimoto, Eriko Sato, et al.
Oncology Reports|October 4, 2019
Potential role for second‑generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysisMaho Ishikawa, Noriyoshi Iriyama, Michihide Tokuhira, et al.
Cancer Medicine|October 10, 2020
The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohortEriko Sato, Noriyoshi Iriyama, Michihide Tokuhira, et al.
Annals of Hematology|June 28, 2018
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group databaseIsao Fujioka, Tomoiku Takaku, Noriyoshi Iriyama, et al.
International Journal of Hematology|December 31, 2015
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignanciesKatsuhiro Miura, Masaru Nakagawa, Hiromichi Takahashi, et al.
Therapeutic Drug Monitoring|July 20, 2019
Increased Arbekacin Clearance in Patients With Febrile NeutropeniaTakahiro Nakayama, Masayuki Chuma, Naohiro Tochikura, et al.
Cancer Science|November 21, 2024
Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-OFumihiko Hayakawa, Naoki Mori, Kiyotoshi Imai, et al.
International Journal of Hematology|April 8, 2024
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study GroupNoriyoshi Iriyama, Eisaku Iwanaga, Yuta Kimura, et al.
Expert Review of Anticancer Therapy|April 7, 2025
Contemporary management of diffuse large B-cell lymphoma in JapanKatsuhiro Miura, Hiromichi Takahashi, Haruna Nishimaki-Watanabe, et al.
Leukemia Research|September 29, 2006
Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival ratesMasamitsu Yanada, Itsuro Jinnai, Jin Takeuchi, et al.
Pageof 13